Tilray Shares Face Pressure Amid Regulatory Delays and Sector-Wide Challenges

Tilray Brands, a leading cannabis producer, experienced a significant downturn on Thursday, with its shares declining 5.21% to close at $1.19. The session was marked by volatility; after posting intraday gains of 4.3%, investor sentiment reversed sharply. The broader cannabis sector continues to face headwinds from persistent regulatory uncertainty, particularly concerning FDA approval processes and complex federal guidelines.

All eyes are on the company’s upcoming earnings report, scheduled for release before the market opens on October 9. A conference call for investors will follow at 8:30 a.m. Eastern Time. The results will cover the first quarter of Tilray’s fiscal year 2026, which ended on August 31.

Market experts have issued the following consensus estimates for the quarter:
– Loss per share:... Read more...